Release
2026/02/24
OSAKA, Japan, February 24, 2026 - Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") announces as follows that, at the meeting of its Board of Directors held on February 20, 2026, we have decided on the candidate for director to be proposed at the 161st Annual General Meeting of Shareholders scheduled on June 24.
Candidate for Director (Scheduled to be appointed on June 24, 2026)
New position |
Name |
Present Position |
Independent Outside Director |
Keiichi Yoshii |
Daiwa House Industry Co., Ltd. Representative Director and Chairman, Chief Executive Officer (CEO); Head of Overseas Division |
Refference:
Career summary of Candidate for Director
Name |
Keiichi Yoshii |
Date of birth |
May 27, 1958 |
Career summary |
June 1990: Joined Daiwa House Industry Co., Ltd. April 2010: Executive Officer, Deputy General Manager, Overseas Division June 2011: Director and Senior Executive Officer, General Manager, Overseas Division (In charge of Overseas Business) April 2013: Director and Managing Executive Officer, Tokyo Head Branch Manager April 2016: Director and Senior Managing Executive Officer, Tokyo Head Branch Manager; General Manager, Marketing Headquarters November 2017: Representative Director and President, Chief Operating Officer (COO) June 2019: Representative Director and President, CEO and COO April 2025: Representative Director and Chairman, CEO; Head of Overseas Division (Current) |
Forward-Looking Statements
This announcement contains forward-looking statements. These statements are based on expectations in light of the information currently available, assumptions that are subject to risks and uncertainties which could cause actual results to differ materially from these statements. Risks and uncertainties include general domestic and international economic conditions such as general industry and market conditions, and changes of interest rate and currency exchange rate. These risks and uncertainties particularly apply with respect to product-related forward-looking statements. Product risks and uncertainties include, but are not limited to, completion and discontinuation of clinical trials; obtaining regulatory approvals; claims and concerns about product safety and efficacy; technological advances; adverse outcome of important litigation; domestic and foreign healthcare reforms and changes of laws and regulations. Also for existing products, there are manufacturing and marketing risks, which include, but are not limited to, inability to build production capacity to meet demand, lack of availability of raw materials and entry of competitive products. The company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
For Further Information, Contact:
SHIONOGI Website Inquiry Form: https://www.shionogi.com/global/en/contact.html